ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
128.150,71
-0,10%
S&P 500
5.303,27
0,12%
US Dollar vs BRL
5,1047
0,00%
Bitcoin
67.122,32
0,06%
Brent Oil
83,76
0,00%
Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. Entasis Therapeutics Holdings Inc (ETTX)

  7. Entasis Therapeutics Holdings Inc (ETTX) Notícias

ETTX

Entasis Therapeutics (ETTX)

Entasis Therapeutics Holdings Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:ETTX
DataHoraFonteTítuloCódigoCompanhia
12/10/202209:30GlobeNewswire Inc.Entasis Therapeutics, a Wholly Owned Subsidiary of Innoviva, Announces Data on SUL-DUR to be Presented at IDWeek 2022NASDAQ:ETTXEntasis Therapeutics Holdings Inc
21/07/202218:28Edgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
11/07/202218:27Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
11/07/202218:17Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
11/07/202218:13Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
11/07/202217:11Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
08/07/202218:05Edgar (US Regulatory)Amended Statement of Ownership: Private Transaction (sc 13e3/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
08/07/202218:02Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (sc 14d9/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
08/07/202217:49Edgar (US Regulatory)Amended Tender Offer Statement by Third Party (sc To-t/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
08/07/202209:35Business WireInnoviva Announces Expiration of Cash Tender Offer for Shares of Entasis Therapeutics Holdings Inc.NASDAQ:ETTXEntasis Therapeutics Holdings Inc
07/06/202210:05Edgar (US Regulatory)Tender Offer Statement by Third Party (sc To-t)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
24/05/202219:36PR Newswire (US)ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Entasis Therapeutics Holdings Inc.NASDAQ:ETTXEntasis Therapeutics Holdings Inc
23/05/202217:19Edgar (US Regulatory)Written Communication by the Subject Company Relating to a Third Party Tender Offer (sc14d9c)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
23/05/202217:17Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
02/05/202217:06Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
27/04/202217:19Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
27/04/202207:16TipRanksEntasis Therapeutics Holdings (ETTX) Gets a Hold Rating from H.C. WainwrightNASDAQ:ETTXEntasis Therapeutics Holdings Inc
08/03/202209:32TipRanksWedbush Downgrades Entasis Therapeutics Holdings (ETTX) to HoldNASDAQ:ETTXEntasis Therapeutics Holdings Inc
04/03/202208:27TipRanksAnalyst Explains Why They Downgraded Their Rating on Entasis Therapeutics Holdings (ETTX)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
03/03/202218:07Edgar (US Regulatory)Annual Report (10-k)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
25/02/202219:05Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
14/02/202213:44Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
19/10/202110:00GlobeNewswire Inc.Zai Lab and Entasis Therapeutics Announce Positive Topline Results for Sulbactam-Durlobactam (SUL-DUR) from Phase 3 ATTACK TrialNASDAQ:ETTXEntasis Therapeutics Holdings Inc
27/08/202119:08Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
06/08/202107:12Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
02/08/202117:40Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
19/07/202117:06Edgar (US Regulatory)Amended Tender Offer Statement by Issuer (sc To-i/a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
17/06/202117:17Edgar (US Regulatory)Tender Offer Statement by Issuer (sc To-i)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
17/05/202112:03Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
05/05/202117:46Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:ETTXEntasis Therapeutics Holdings Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:ETTX

Seu Histórico Recente

NYSE
AGM.A
Federal Agricultural Mor...
LSE
0L6Z
Sirius Xm
NYSE
KGC
Kinross Gold
LSE
0UC3
Norwegian Cruise Line
LSE
0N4O
Salini Impregilo
Delayed Upgrade Clock
ADVFN Logo

Brasil
Empresa
Negócios
Popular
Obter o aplicativo

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados